Search research articles
Contact Us
Filters
Showing results (21-30 of 39) with videos related to
Page
of 4
Sort By:
Urology
|
June 1, 1997
Prognostic significance of prostate-specific antigen in stage T1c prostate cancer treated by radical prostatectomy
M S Cookson, N E Fleshner, S M Soloway, et al.
Urology
|
October 8, 1998
Repeat transrectal ultrasound-guided prostate biopsy: a strategy to improve the reliability of needle biopsy grading in patients with well-differentiated prostate cancer
N E Fleshner, M S Cookson, S M Soloway, et al.
The Journal of Urology
|
February 1, 1997
Correlation between Gleason score of needle biopsy and radical prostatectomy specimen: accuracy and clinical implications
M S Cookson, N E Fleshner, S M Soloway, et al.
JAMA
|
February 6, 1991
Independent prognostic factors in patients with metastatic (stage D2) prostate cancer. The Zoladex Study Group
G W Chodak, N J Vogelzang, R J Caplan, et al.
Anti-Cancer Drugs
|
October 1, 1990
'Acute on chronic' effect of depot leuprolide in patients with stage D2 cancer of prostate
R Sharifi, M Soloway, M Clayton, et al.
European Urology
|
February 21, 1998
Casodex 10-200 mg daily, used as monotherapy for the treatment of patients with advanced prostate cancer. An overview of the efficacy, tolerability and pharmacokinetics from three phase II dose-ranging studies. Casodex Study Group
C J Tyrrell, L Denis, D Newling, et al.
Urology
|
March 1, 1997
PSA levels and the rate of positive surgical margins in radical prostatectomy specimens preceded by androgen blockade in clinical B2 (T2bNxMo) prostate cancer. The Lupron Depot Neoadjuvant Study Group
D G McLeod, C F Johnson, E Klein, et al.
The Journal of Urology
|
December 1, 1988
Intravesical thiotepa versus mitomycin C in patients with Ta, T1 and TIS transitional cell carcinoma of the bladder: a phase III prospective randomized study
N M Heney, W W Koontz, B Barton, et al.
The Journal of Urology
|
November 1, 1992
A randomized, placebo-controlled multicenter study of the efficacy and safety of terazosin in the treatment of benign prostatic hyperplasia
H Lepor, S Auerbach, A Puras-Baez, et al.
Progress in Clinical and Biological Research
|
January 1, 1990
The prognostic value of the pT-category after combination chemotherapy for patients with invasive bladder cancer who underwent cystectomy. EORTC-GU group
T A Splinter, H I Scher, L Denis, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 39) with videos related to
Sort By:
Page
of 4
Urology
|
June 1, 1997
Prognostic significance of prostate-specific antigen in stage T1c prostate cancer treated by radical prostatectomy
M S Cookson, N E Fleshner, S M Soloway, et al.
Urology
|
October 8, 1998
Repeat transrectal ultrasound-guided prostate biopsy: a strategy to improve the reliability of needle biopsy grading in patients with well-differentiated prostate cancer
N E Fleshner, M S Cookson, S M Soloway, et al.
The Journal of Urology
|
February 1, 1997
Correlation between Gleason score of needle biopsy and radical prostatectomy specimen: accuracy and clinical implications
M S Cookson, N E Fleshner, S M Soloway, et al.
JAMA
|
February 6, 1991
Independent prognostic factors in patients with metastatic (stage D2) prostate cancer. The Zoladex Study Group
G W Chodak, N J Vogelzang, R J Caplan, et al.
Anti-Cancer Drugs
|
October 1, 1990
'Acute on chronic' effect of depot leuprolide in patients with stage D2 cancer of prostate
R Sharifi, M Soloway, M Clayton, et al.
European Urology
|
February 21, 1998
Casodex 10-200 mg daily, used as monotherapy for the treatment of patients with advanced prostate cancer. An overview of the efficacy, tolerability and pharmacokinetics from three phase II dose-ranging studies. Casodex Study Group
C J Tyrrell, L Denis, D Newling, et al.
Urology
|
March 1, 1997
PSA levels and the rate of positive surgical margins in radical prostatectomy specimens preceded by androgen blockade in clinical B2 (T2bNxMo) prostate cancer. The Lupron Depot Neoadjuvant Study Group
D G McLeod, C F Johnson, E Klein, et al.
The Journal of Urology
|
December 1, 1988
Intravesical thiotepa versus mitomycin C in patients with Ta, T1 and TIS transitional cell carcinoma of the bladder: a phase III prospective randomized study
N M Heney, W W Koontz, B Barton, et al.
The Journal of Urology
|
November 1, 1992
A randomized, placebo-controlled multicenter study of the efficacy and safety of terazosin in the treatment of benign prostatic hyperplasia
H Lepor, S Auerbach, A Puras-Baez, et al.
Progress in Clinical and Biological Research
|
January 1, 1990
The prognostic value of the pT-category after combination chemotherapy for patients with invasive bladder cancer who underwent cystectomy. EORTC-GU group
T A Splinter, H I Scher, L Denis, et al.
Page
of 4